Market Place
Sourcing Support
Mundipharma, Vectura To Reformulate Flutiform® For Lower Emissions
16 Apr 2024 //
BUSINESSWIRE
GSK to cap out-of-pocket inhaler costs in US
21 Mar 2024 //
REUTERS
XHANCE Approved by FDA as First and Only Medication for Chronic Rhinosinusitis
16 Mar 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of February 28, 2024
28 Feb 2024 //
FDA
GSK to cut US prices for Advair, Valtrex and Lamictal
23 Dec 2023 //
REUTERS
GSK looks to authorized generic version of asthma treatment
12 Oct 2023 //
ENDPTS
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
FDA accepts sNDA for Optinose’s XHANCE
05 May 2023 //
PHARMAFILE
Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion
21 Feb 2023 //
GLOBENEWSWIRE
Drugmakers benefit `substantially` from secondary patents on inhalers — study
03 Jan 2023 //
ENDPTS
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Optinose Looking For A Partner To Optimize Big Opportunity In Chronic Sinusitis
14 Jun 2022 //
PHARMAINTELLIGENCE
Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE
28 Oct 2021 //
GLOBENEWSWIRE
Enforcement Report- Week of October 27, 2021
27 Oct 2021 //
FDA
Ellodi Announces New Data to Be Presented at Digestive Disease Week®
21 May 2021 //
BUSINESSWIRE
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®
21 Sep 2020 //
BLOOMBERG
Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent® Diskus®
17 Aug 2020 //
PRNEWSWIRE
Cipla submits application with USFDA for generic version of asthma drug
18 May 2020 //
ECONOMICTIMES
GSK books 19% sales growth for first quarter
29 Apr 2020 //
PHARMATIMES
Cipla share price up 8% on successful completion of Ph-3 study of asthma drug
02 Apr 2020 //
MONEYCONTROL
FDA Requires Boxed Warning for Singulair, Generics
05 Mar 2020 //
RAPS
Teva announces FDA approval of ArmonAir Digihaler inhalation powder
24 Feb 2020 //
NJBIZ
Teva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate)
24 Feb 2020 //
BUSINESSWIRE
Pfizer, BMS, AbbVie and others raise prices to ring in 2020
03 Jan 2020 //
FIERCE PHARMA
GSK leans on respiratory franchise with Trelegy share-grab
30 Oct 2019 //
FIERCE PHARMA
FDA knocks back AstraZeneca`s respiratory ambitions
02 Oct 2019 //
BIOPHARMADIVE
Charging at blockbuster Advair, Novartis boasts topline victories
30 Sep 2019 //
ENDPTS
Product Hopping: E&C Hearing Addresses Restrictions to Generic Competition
19 Sep 2019 //
RAPS
The top 10 franchise drugs in biopharma history will earn $1.4T (trillion)
16 Aug 2019 //
ENDPTS
New respiratory drugs, Shingrix help GSK weather Advair generics
25 Jul 2019 //
FIERCE PHARMA
AstraZeneca’s COPD triplet Breztri nabs first nod from Japan
20 Jun 2019 //
FIERCE PHARMA
GSK pharma head flags need for speed in high-pressure drug market
17 Jun 2019 //
REUTERS
Novartis` asthma triplet beats GSK`s Advair in phase 2 trial
23 May 2019 //
FIERCE BIOTECH
Mylan investors are fed up with management, analysts say
09 May 2019 //
FIERCE PHARMA
Generic Advair hits GSK revenues hard
01 May 2019 //
BIOPHARMADIVE
Hi-Tech `s Generic Fluticasone Propionate Receives Approval in US
19 Apr 2019 //
FDA
Biotech shares continue to fall on FDA uncertainty
08 Mar 2019 //
CNBC
Mylan`s Advair generic pressures GSK with strong launch
08 Mar 2019 //
BIOPHARMADIVE
Mylan shares sink as bleak profit outlook sparks growth concerns
28 Feb 2019 //
CNBC
UBS strips GSK of ‘buy’ recommendation on fears for its ViiV HIV division
23 Feb 2019 //
PROACTIVE INVESTOR
Mylan`s generic Advair discount not as big as it looks: analysts
14 Feb 2019 //
FIERCE PHARMA
Enforcement Report - Week of February 13, 2019
13 Feb 2019 //
FDA
Hal Barron’s GSK team continues to cull resp drugs in big shift to oncology R&D
06 Feb 2019 //
ENDPTS
Innovus Pharma’s Product FlutiCare® Ranks #2 Behind Flonase®
04 Feb 2019 //
BUSINESSWIRE
Mylan Wins FDA Approval for First Advair Generic
01 Feb 2019 //
RAPS
FDA approves first generic Advair Diskus
31 Jan 2019 //
FDA
FDA approves Mylan’s generic version of Advair asthma treatment
31 Jan 2019 //
CNBC
GSK about to see Mylan’s generic carve into its mega-blockbuster Advair franchise
31 Jan 2019 //
ENDPTS
EMA approves Flutiform for children with asthma
14 Jan 2019 //
PHARMA TIMES
Vectura sinks after PhIII asthma trial ends in failure, marking another setback
26 Nov 2018 //
ENDPTS
That generic Advair you`ve been expecting for months? It`ll come, Mylan says
07 Nov 2018 //
FIERCE PHARMA
Mylan`s Beat Lifts Hopes That Worst Is Over for Generic Drugs
06 Nov 2018 //
BLOOMBERG
GlaxoSmithKline expands API production for COPD inhalers
24 Oct 2018 //
FIERCE PHARMA
Starring in That Drug Commercial? An Actual Patient
24 Sep 2018 //
NY TIMES
Mylan reveals its $463M mystery buy - Novartis` TOBI cystic fibrosis products
07 Sep 2018 //
FIERCE PHARMA
AZ rival to GSK’s COPD drug Anoro fails head-to-head test
24 Aug 2018 //
PMLIVE
Hit by surprise setback, AZ explains why inhaler beaten by GSK rival
23 Aug 2018 //
ENDPTS
Enforcement Report - Week of August 15, 2018
15 Aug 2018 //
FDA
GSK chief rounds out her top team with CFO pick — but performance lags
08 Aug 2018 //
ENDPTS
